Tissue penetration and exposure of cefepime in patients with diabetic foot infections

International Journal of Antimicrobial Agents

Volumn 47, Issue 3, 2016, Pages 247-248

  So, Wonhee ^a   Kuti, Joseph L ^a   Shepard, Ashley ^a   Nugent, James ^a   Nicolau, David P ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; DIABETIC FOOT; DIABETIC FOOT INFECTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG PENETRATION; DRUG TISSUE LEVEL; FOOT DISEASE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; LETTER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECOMMENDED DRUG DOSE; DIABETES MELLITUS; DRUG EFFECTS; FOOT DISEASES; MICROBIOLOGY; PSEUDOMONAS INFECTIONS;

CEPHALOSPORINS; DIABETES MELLITUS; FOOT DISEASES; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84960307553     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.01.002     Document Type: Letter

References (5)

1. A.A. Bhalodi, S.T. Housman, A. Shepard, J. Nugent, and D.P. Nicolau Tissue pharmacokinetics of cefazolin in patients with lower limb infections Antimicrob Agents Chemother 57 2013 5679 5683
2. R.H. Barbhaiya, S.T. Forgue, W.C. Shyu, E.A. Papp, and K.A. Pittman High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine Antimicrob Agents Chemother 31 1987 55 59
3. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement. Document M100-S25 2015 CLSI Wayne, PA
4. Y. Hamada, C.A. Sutherland, and D.P. Nicolau Impact of revised cefepime CLSI breakpoints on Escherichia coli and Klebsiella pneumoniae susceptibility and potential impact if applied to Pseudomonas aeruginosa J Clin Microbiol 53 2015 1712 1714
5. J.L. Crandon, C.C. Bulik, J.L. Kuti, and D.P. Nicolau Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa Antimicrob Agents Chemother 54 2010 1111 1116